We found clear evidence that DLX6-AS1 contributed to the progression of prostate cancer by accelerating malignant phenotypes of cells and lymph node metastasis through facilitating the DNMT1-mediated LARGE methylation (Figure 6). The gene discussed is DLX6; the disease is prostate cancer.